Adam Miller

Senior Writer

Adam Miller is senior digital writer with CBC News. He's covered health, politics and breaking news extensively in Canada, in addition to several years reporting on news and current affairs throughout Asia.

Latest from Adam Miller

Second Opinion

'It's torture': Is a mysterious cannabis-related illness underdiagnosed in Canada?

A mysterious cannabis-related illness is turning up in emergency rooms in Canada, but exactly what causes it is unknown.
Second Opinion

Why studying music and the brain is so fascinating, and so difficult

New research is shedding light on what we know about how the brain interacts with music, but it also highlights how challenging it is to study effectively due to the highly personalized nature of how we interpret it.
Second Opinion

Cannabis isn't a proven treatment for mental health disorders, but experts say it shouldn't be ruled out

A review of 40 years' worth of studies suggests cannabis may not be effective in treating mental health disorders, but experts say that might have more to do with the lack of high-quality research than the drug itself.

Trick or truth? The real story behind Halloween candy tampering

As kids around the country prepare to hit their neighbourhood streets for the annual trick-or-treating ritual, we examine how real the threat of poisoned candies, razors in apples and other Halloween treat tampering we've heard about for decades really is in Canada.
Second Opinion

'Under threat': Why experts say U.S. import of Canadian drugs could put supply at risk

U.S. President Donald Trump is calling for quick action to allow Canadian drugs to be imported into the U.S. But experts say the move has the potential to put our drug supply at risk of further shortages in the future.
Second Opinion

Could a common treatment for joint pain do more harm than good?

A common treatment for a chronic pain condition that affects millions of Canadians may not be as safe as once thought, and experts say a growing body of research shows it could be doing more harm than good.
Second Opinion

What you need to know before flu season hits in Canada

As Canada braces for another flu season, experts say it’s difficult to predict the severity of the virus and the effectiveness of the flu shot this year, but global trends may hold clues as to what’s in store for us.
Second Opinion

Why the opioid crisis isn't a bigger federal election issue

The death toll from the opioid crisis has skyrocketed since the last federal election, but experts and advocates calling for more political action say it's not being prioritized by the federal leaders in this year's campaign because of the stigma of drug use and a need to appear tough on crime.
Second Opinion

If the U.S. loses its measles elimination status, could Canada be next?

The U.S. could lose its measles elimination status for the first time in almost 20 years this week, and experts say declining vaccination rates and the threat of outbreaks may put Canada at similar risk in the future.
Second Opinion

What Purdue Pharma's bankruptcy filing means for Canada

Purdue Pharma has filed for bankruptcy in the United States, but what does that mean for the lawsuits in Canada over the opioid crisis? The concern in Canada is that because of the U.S. bankruptcy filing, the assets at the centre of the lawsuit could be in jeopardy.

The science behind why vaping is becoming so popular in Canada

Vaping has become a lot more popular in Canada in a short period of time, despite what little is known of its long-term health effects.
Exclusive

2,000% rise in street drug samples testing positive for fentanyl

The number of positive tests for fentanyl in samples of street drugs seized by law enforcement agencies across Canada has grown at a rate of more than 2,000 per cent over five years, according to exclusive data obtained by CBC News.